Overview

Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers

Status:
Not yet recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess bioequivalence of the granule formulation of alpelisib as compared to the film-coated tablet formulation in healthy volunteers in the fed state. In addition, the food effect of the granule formulation will be investigated between the fed state and the fasted state.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis Pharmaceuticals